O-linked β-N-acetylglucosamine modification in diabetic foot ulcer pathogenesis

Area of Science:

• Biochemistry
• Molecular Biology
• Endocrinology

Background:

• O-linked β-D-N-acetylglucosamine (O-GlcNAc) is a posttranslational modification regulated by O-GlcNAc transferase and O-GlcNAcase.
• Emerging evidence links O-GlcNAc modification to the pathogenesis of diabetic foot ulcers (DFUs).

Purpose of the Study:

• To review the pathogenesis of DFUs.
• To explore the correlation between protein O-GlcNAc modification and DFUs.
• To offer insights into potential diagnosis and treatment strategies for DFUs.

Main Methods:

• Literature review focusing on O-GlcNAc modification and DFU pathogenesis.
• Analysis of molecular mechanisms linking high glucose, O-GlcNAc, and DFU-related complications.
• Synthesis of current research on protein O-GlcNAc modification in diabetic complications.

Main Results:

• Elevated O-GlcNAc levels in high-glucose conditions contribute to DFU pathogenesis.
• O-GlcNAc modification affects proteins crucial for peripheral neuropathy, vascular disease, and wound healing.
• Key pathological processes in DFUs, including inflammation and impaired tissue remodeling, are influenced by O-GlcNAc.

Conclusions:

• Protein O-GlcNAc modification plays a significant role in the development and progression of diabetic foot ulcers.
• Understanding the O-GlcNAc pathway offers potential for novel diagnostic and therapeutic interventions for DFUs.
• Targeting O-GlcNAc modification may provide a new avenue for managing diabetic complications.